Peer-reviewed veterinary case report
Young cat with muscle stiffness and missing sarcoglycan proteins
By Doroudi, Arian et al.·Published in Journal of Feline Medicine and Surgery Open Reports·2026·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: EXPRESS: Sarcoglycanopathy with absent expression of all sarcoglycan proteins in a young cat with clinical features of feline hypertrophic muscular dystrophy
- Species:
- cat
Plain-English summary
A 1-year-old male domestic shorthair cat was brought in for ongoing mobility issues and muscle stiffness, which started when he was just 3 months old. The vet found that his muscle enzyme levels were extremely high, and a muscle biopsy confirmed he had a type of muscular dystrophy. This condition caused symptoms like an enlarged tongue and muscle growth in certain areas, but he didn't show pain or nerve issues. Although the cat's condition is serious, he has remained stable for two months after diagnosis, indicating a slow progression of the disease.
People also search for: cat muscle stiffness · cat mobility decline · feline muscular dystrophy treatment · why is my cat's tongue swollen · elevated muscle enzymes in cats
Abstract
Case summary: A 1-year-old male castrated domestic shorthair cat presented for chronic mobility decline and muscle stiffness, first noted at 3 months of age, and persistently elevated serum creatine kinase levels (>19,000-53,000 IU/L). Clinical examination revealed macroglossia and selective hypertrophy of cervical and appendicular muscles. Neurologic evaluation indicated a myopathic gait without pain or neurologic deficits. Muscle biopsy was supportive of muscular dystrophy and immunohistochemistry demonstrated loss of the sarcoglycan complex with complete absence of all tested sarcoglycan proteins, consistent with a diagnosis of sarcoglycan-deficient muscular dystrophy. These findings contrast prior feline reports which were mostly limited to reduction or absence of β-sarcoglycan on immunostaining without overt clinical evidence of muscular dystrophy. A follow-up echocardiogram revealed mild to moderate right ventricular changes without indications for treatment. At two months post-diagnosis, the patient remained clinically static, suggesting a relatively slow progression despite absent sarcoglycan expression. Relevance and novel information: This case represents the first reported feline sarcoglycanopathy characterized by absence of all tested sarcoglycan subunits on immunohistochemistry and concurrent presentation of classic Duchenne-like muscular dystrophy signs, including macroglossia and muscular hypertrophy. It expands the phenotypic spectrum of muscular dystrophies in cats, underscoring parallels to limb-girdle muscular dystrophies in humans and dogs. Given the cat’s static clinical course and diagnostic overlap with dystrophinopathies, this case suggests sarcoglycan-deficient muscular dystrophy in cats may present with a broader spectrum of severity than previously appreciated. The findings support the potential utility of feline sarcoglycanopathies, when phenotypically consistent with forms appreciated in other species, as spontaneous animal models for comparative medical research.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.1177/20551169261442339